Latest Insights - page 36 | BiopharmaTrend

IQVIA Introduces a Compact Medical Reasoning LLM Outscoring Larger Models

IQVIA has launched Med-R1 8B, a medical reasoning large language model (LLM) designed to assist healthcare professionals in interpreting complex clinical data and scientific literature. Tailored specifically for the healthcare …

Continue ›››

Verge Genomics Reports Digital Biomarkers May Track Early ALS Progression in Pre-Treatment Trial Phase

New findings from Verge Genomics suggest that digital clinical biomarkers can detect short-term ALS progression even before treatment begins, offering a potential shift in how early-stage efficacy is measured in …

Continue ›››

Aelius Biotech Raises £750K to Expand In Vitro Gut Model Platform for Drug and Food R&D

Aelius Biotech, a Newcastle-based biotech company developing a non-animal laboratory gut model, has secured an additional £750,000 from the North East Venture Fund (backed by the European Regional Development Fund …

Continue ›››

Pharma Supply: SkyCell Partners with Microsoft to Launch AI Co-Pilot for Shipment Monitoring

SkyCell, a Swiss company specializing in pharmaceutical logistics, has launched K.AI—an AI-powered chatbot developed in collaboration with Microsoft—to enhance visibility, decision-making, and risk mitigation in pharma supply chains. The system …

Continue ›››

$1B AI Drug Discovery Startup Xaira Therapeutics Appoints Foundation Model Expert Bo Wang as Head of Biomedical AI

Xaira Therapeutics, an AI-driven biotech launched in April 2024 with over $1 billion in funding, has appointed Dr. Bo Wang as Senior Vice President and Head of Biomedical AI. The …

Continue ›››

Paige’s AI Tool for Multi-Tissue Cancer Detection Gets FDA's Breakthrough Device Designation

Paige has received Breakthrough Device designation from the U.S. FDA for PanCancer Detect, an AI-based diagnostic tool intended to assist pathologists in identifying cancer across a range of tissues and …

Continue ›››

Differential Bio Emerges from Stealth with €2M to Scale AI-Driven Biomanufacturing

Differential Bio, a Munich-based startup focused on AI-powered biomanufacturing, has emerged from stealth with €2 million in pre-seed funding. The company is developing a "Virtual Scale-up Platform" that integrates advanced …

Continue ›››

Medtronic Partners with Methinks AI to Expand AI-Driven Stroke Assessment in EMEA

Medtronic, one of the world’s largest medical device companies by revenue, has announced a strategic partnership with Methinks AI to expand stroke care capabilities across Central and Eastern Europe, the …

Continue ›››

Siemens to Acquire Dotmatics for $5.1B

Siemens has announced a $5.1 billion acquisition of Dotmatics from Insight Partners, with closing expected in the first half of fiscal 2026. Dotmatics provides R&D informatics software for life sciences, combining …

Continue ›››

Aqemia Secures $7.4M to Expand RNA-Targeting Programs With Physics-Based Generative AI

Aqemia has announced a $7.4 million grant from the France 2030 investment plan to accelerate its work in RNA-targeted drug discovery. The funding will support the expansion of its generative …

Continue ›››

Isomorphic Labs Raises $600M to Advance AI Drug Design and Internal Pipeline

Isomorphic Labs has secured $600 million in its first external funding round to accelerate the development of its AI-based drug design engine and support the advancement of internal therapeutic programs …

Continue ›››

13 Foundation Models: Startups, Industry Updates and the Nobel Prize

Since our previous overview of foundation models and start-ups in the life science field, a historical event took place on October 9th, 2024: the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John …

Continue ›››